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Incidence and prevalence of lower
extremity tendinopathy in a Dutch general
practice population: a cross sectional study
Iris Sophie Albers1*, Johannes Zwerver1, Ronald Leo Diercks1, Janny Hendrika Dekker2
and Inge Van den Akker-Scheek1
Abstract
Background: Lower extremity tendinopathy is a common sports injury, but it can also affect non-athletes. Because
tendinopathy is difficult to treat and has negative effects on the ability to work and quality of life, development
of preventive interventions is important. The first step in the Van Mechelen prevention model is to determine the
extent of the problem. The primary aim of this study was to determine the incidence and prevalence of lower
extremity tendinopathy in a Dutch general practice population. The secondary aim was to investigate possible
associated factors.
Methods: A cross-sectional study was performed in a Dutch general practice. Using International Classification of
Primary Care codes, the electronic patient files were searched to identify cases of adductor tendinopathy, greater
trochanteric pain syndrome, jumper’s knee, Achilles tendinopathy, and plantar fasciopathy in 2012. The tendinopathy
patients were compared to the general practice population regarding age, gender, use of medication, and comorbidity
using 95 % confidence intervals.
Results: The prevalence and incidence rates of lower extremity tendinopathy found in this study were 11.83 and 10.52
per 1000 person-years. Lower extremity tendinopathy was more prevalent among older patients. No differences
between tendinopathy patients and the general practice population were found regarding gender, use of
medication, or comorbidity.
Conclusions: In this cross-sectional study in a Dutch general practice, the prevalence and incidence rates of
lower extremity tendinopathy were 11.83 and 10.52 per 1000 person-years. Lower extremity tendinopathy
deserves a higher place in locomotor system research to develop preventive interventions.
Keywords: Epidemiology, Patellar, Tendinitis, Tendonitis, Tendon, Fasciitis, Heel, Spur
Background
Lower extremity tendinopathy is a common injury in
athletes, but it can also develop in non-athletes [1, 2].
Because tendinopathy can be difficult to treat and
might have negative effects on not only sports partici-
pation, but also on the ability to work and quality of
life [3, 4], development of preventive interventions is
of utmost importance.
The first step in the Van Mechelen model for prevention
is to determine the extent of the problem [5]. The inci-
dence and prevalence of lower extremity tendinopathy
among specific sports populations have been established
[6–9]. However, these numbers are largely lacking for the
general practice population. The epidemiology of only two
lower extremity tendinopathies – Achilles tendinopathy
and greater trochanteric pain syndrome – have been stud-
ied in Dutch general practice populations [2, 10]. There-
fore, the primary aim of this study was to determine the
incidence and prevalence of lower extremity tendinopathy
among a population visiting a Dutch general practice.
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The second step in the Van Mechelen model is to de-
termine risk factors. In previous studies, several factors
have been investigated for a possible association with the
development of tendinopathy. Aside from increasing age
[11, 12], gender differences [13], and use of medication
(corticosteroids, fluoroquinolones, and statins) [14–16],
co-morbidities that have been linked to tendinopathy are
hypertension, dyslipidaemia, and diabetes mellitus [17].
The secondary aim of this study was to investigate
whether in this general practice population an associ-
ation between tendinopathy and gender, age, use of
medication, or co-morbidities could be found.
Methods
To determine the incidence and prevalence of lower
extremity tendinopathy in a Dutch general practice
population, a cross-sectional study was performed at
the Academic General Practice Groningen. This group
practice of eight general practitioners with more than
10,500 registered patients is part of the morbidity and
medication Registration Network Groningen (RNG),
which systematically collects patient data in a longitu-
dinal database. The practice was visited to identify
cases of lower extremity tendinopathy in the elec-
tronic patient files. The following tendinopathies were
investigated: adductor tendinopathy, greater trochan-
teric pain syndrome, jumper’s knee, Achilles tendino-
pathy, and plantar fasciopathy. Like other general
practices in the Netherlands, the Academic General
Practice Groningen uses International Classification of
Primary Care (ICPC) codes [18] to document the reason
of a patient’s visit. An ICPC code consists of a letter and
two numbers, and represents a disease or a symptom. Be-
cause there are no specific ICPC codes for lower extremity
tendinopathies, a combination of ICPC codes that the
general practitioner could have used in the case of lower
extremity tendinopathy was used in this study (Table 1).
All patient contacts of the year 2012 that matched one of
these ICPC codes were studied by ISA to identify cases of
tendinopathy.
Because we investigated more than one tendinopathy,
there was not a single set of inclusion criteria. Instead, we
formulated the inclusion criteria per tendinopathy (Table 2).
Patients with bilateral symptoms of one tendinopathy were
scored as one case for that specific tendinopathy. Patients
with symptoms of two or more different tendinopathies
were scored as one case for each of the separate tendinopa-
thies. Patients with tendon ruptures were excluded.
To investigate possible associated factors, we docu-
mented age, gender, use of systemic corticosteroids, fluoro-
quinolones, or statins in the six months before diagnosis,
and if the patient suffered from one of the following co-
morbidities: diabetes mellitus (defined as ICPC code T90,
T90.01, or T90.02), hypertension (defined as ICPC code
K86 or K87), and dyslipidaemia (defined as ICPC code
T93). We also documented the presence of overweight, de-
fined as an ICPC code (T82 and T83 stand for obesity and
overweight, respectively) or a remark about overweight by
the general practitioner in the patient file. In addition, we
documented the duration of symptoms before the patient
visited the general practitioner, and the patient’s sports ac-
tivities, if this information was available from the patient
file.
The number of prevalent and incident cases was di-
vided by the number of person-years in the practice
population to determine a prevalence rate (PR) and inci-
dence rate (IR) per 1000 person-years. We used the
amount of person-years, because the population of a
general practice is dynamic. Throughout the year, the
population increases and decreases as a result of birth,
Table 1 ICPC codes and corresponding symptoms/diagnoses
Code Symptom Code Diagnosis









L99.08 Heel spur/plantar fasciitis
L29 Other/multiple symptoms/
complaints locomotor system
Table 2 Inclusion criteria per tendinopathy
Adductor related tendinopathy, one of the following
- Diagnosis tendinopathy/tendinitis of the hip adductors
- Pain in groin during adduction against resistance
- Pain located at the insertion of the hip adductors on the pubic bone
Greater trochanteric pain syndrome, one of the following
- Diagnosis greater trochanteric pain syndrome/trochanteric bursitis
- Pain on palpation of the greater trochanter
Jumper’s knee, one of the following
- Diagnosis jumper’s knee, tendinopathy/tendinitis of patellar
tendon or quadriceps tendon
- Pain located at the insertion of the quadriceps tendon on the patella
- Pain located in the patellar tendon or its insertion on patella or
tibial tuberosity
Achilles tendinopathy, one of the following
- Diagnosis tendinopathy/tendinitis of Achilles tendon
- Pain located in Achilles tendon or its insertion on calcaneus
Plantar fasciopathy, one of the following
- Diagnosis plantar fasciitis/fasciopathy or heel spur
- Pain in plantar fascia or its insertion on calcaneus
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death, and migration. The difference between incidence
and prevalence was based on patient history. If there
had been contacts for the same symptom in 2011, the
patient was scored as a prevalent case only. If a patient
had not visited the general practitioner for the same
symptom in 2011, he or she was scored as both an inci-
dent and a prevalent case in 2012.
The tendinopathy patient data were compared to data
of the general practice population that were obtained
from the annual report of the RNG. We constructed
95 % confidence intervals to test for differences between
the tendinopathy patients and the general practice popu-
lation regarding gender, age, use of medication, and co-
morbidities. If the confidence intervals overlapped, the
difference was not considered statistically significant. If
the confidence intervals did not overlap, the difference
was considered statistically significant. SPSS version 22
was used to analyse the data.
Ethics
The study protocol was reviewed and exempted from
requiring ethics approval by the medical ethical com-
mittee of the University Medical Center Groningen
(METc 2013/516).
Upon registration at the Academic General Practice,
patients included in this study gave informed consent to
the use of their anonymized data by the Registration
Network Groningen.
Results
Between January and April 2014, the Academic General
Practice was visited to search the electronic patient files.
In 2012, the Academic General Practice contained 10,651
person-years. The combination of ICPC codes provided
1091 hits in the electronic database. Based on the consult-
ation reports, 126 prevalent cases of lower extremity
tendinopathy were identified. Fourteen of these patients
had visited the general practitioner in 2011 for the same
symptoms. This led to a prevalence rate (PR) of 11.83 per
1000 person-years, and an incidence rate (IR) of 10.52 per
1000 person-years. The PR and IR per tendinopathy are
shown in Table 3 (Table 3).
The demographics of the tendinopathy patients and
the practice population are shown in Table 4 (Table 4).
There was no statistically significant difference in the
percentages of men and women. The mean age of the
tendinopathy patients was significantly higher than the
mean age of the practice population.
Twelve of the 126 tendinopathy patients had diabetes
(9.5 %; 95 % CI 4.3–14.6 %). This percentage was twice
as high as the percentage of patients with diabetes in the
general practice population (4.8 %) [19], but the differ-
ence was not statistically significant. Of the tendinopathy
patients, 22 had hypertension. The general practitioners
made a distinction between essential hypertension (ICPC
code K86) and hypertension with organ damage (ICPC
code K87). Eighteen tendinopathy patients had essential
hypertension. This percentage (14.3 %; 95 % CI 8.1–
20.5 %) was not significantly higher than the percentage
in the general practice population (11.4 %) [19]. Ten ten-
dinopathy patients had dyslipidaemia (7.9 %).
Fifteen tendinopathy patients used statins (11.9 %; 95 %
CI 6.2–16.6 %). This percentage was not significantly
higher than the percentage of patients using antilipaemic
medication in the total practice population (7.3 %) [19].
Three tendinopathy patients were treated with systemic
corticosteroids (2.4 %) and one tendinopathy patient was
treated with fluoroquinolones (0.7 %) before the start of
the symptoms.
Obesity or overweight were reported in fourteen cases
(11.1 %), but no exact data concerning BMI were avail-
able. A relationship with sports activities was described
in 37 cases (29.4 %). The duration of symptoms before
visiting the general practitioner was reported in 40 cases
and ranged from one day to six years with a mean of
32 weeks.
Discussion
Lower extremity tendinopathy has an incidence rate of
10.52 per 1000 person-years and a prevalence rate of
Table 3 Prevalence rate and incidence rate per tendinopathy
Tendinopathy Prevalence PR Incidence IR
Adductor related tendinopathy 13 1.22 12 1.13
Greater trochanteric pain syndrome 45 4.22 35 3.29
Jumper’s knee 17 1.60 17 1.60
Achilles tendinopathy 25 2.35 23 2.16
Plantar fasciopathy 26 2.44 25 2.34
Total 126 11.83 112 10.52
PR prevalence rate per 1000 person-years, IR incidence rate per 1000 person-
years (practice population = 10,651 person-years)







Male 41.3 % (95 % CI 32.6–50.0) 49 %
Female 58.7 % (95 % CI 50.0–67.4) 51 %
Mean age 46 years (95 % CI 43–49)* 36 years
Age categories
0–17 4.0 % (95 % CI 0.5–7.4)* 16 %
18–44 42.1 % (95 % CI 33.3–50.8) 48 %
45–64 35.7 % (95 % CI 27.2–44.2)* 26 %
65+ 18.3 % (95 % CI 11.4–25.1)* 9 %
95 % CI = 95 % confidence interval, *significant for p ≤ 0.05
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11.83 per 1000 person-years in a Dutch general practice
population. The mean age of the tendinopathy patients
was higher than the mean age of the general practice
population. There were no statistically significant differ-
ences between the tendinopathy patients and the general
practice population regarding gender, use of medication,
or co-morbidities.
This is the first study to investigate the incidence and
prevalence of adductor related tendinopathy, jumper’s
knee, and plantar fasciopathy in a general practice popu-
lation. The incidence and prevalence for Achilles tendi-
nopathy in a general practice population has been
studied once before; our results are similar to the num-
bers found by De Jonge et al. in the Netherlands in 2011
[2]. The incidence of greater trochanteric pain syndrome
was higher than the incidence of 1.8 per 1000 per year
found by Lievense et al. [10]. However, in their study
only 54 % of the originally selected patients responded
to the questionnaire designed to verify the patients’
symptoms, which could introduce a bias and might ex-
plain the difference with our results.
To put the numbers into perspective, the total inci-
dence and prevalence of locomotor system symptoms
seen by Dutch general practitioners are 267 and 397 per
1000 persons per year, respectively [20]. The numbers
found in our study indicate that the incidence of lower
extremity tendinopathy represents 3.0 % of all new loco-
motor system symptoms seen by general practitioners.
In addition, the incidence found for tendinopathy in the
current study was higher than the incidence of osteo-
arthritis in the Dutch general practice population in
2012 (8.4 per 1000 person-years) [21]. While prevention
of osteoarthritis is already high on international research
agendas [22], the prevention of tendinopathy has received
little attention. The negative impact that tendinopathy can
have on the ability to work and quality of life of patients
calls for more research into preventive measures, espe-
cially because the treatment can be difficult [3, 4].
In the current study, the mean age of tendinopathy pa-
tients was significantly higher than the mean age of the
general practice population. Earlier studies have found
tendinopathy to be more prevalent among older people
[11, 12]. The exact mechanism why older tendons seem
to be more prone to damage remains to be elucidated.
One theory attributes the effect to the accumulation of
chronic repetitive damage over time [23]. Another hy-
pothesis is that age-related changes in tendon structure
and biomechanics could decrease the loading capacity
and regenerative capacity of the tendons [24].
We found no significant difference in the percentages
of men and women when we compared the tendinopa-
thy patients to the practice population. Research among
athletes shows different outcomes per tendinopathy. The
male gender is considered a risk factor for jumper’s knee
[13, 25]. Earlier, the male gender was found to be a risk
factor for Achilles tendinopathy as well [26]. However,
in athletes over 40 years of age, Longo et al. did not find
a difference in risk between men and women [27]. Plan-
tar fasciopathy does not seem to have a male or female
predisposition [28].
Although in the current study the prevalence of diabetes
among the tendinopathy patients was twice as high as the
prevalence of diabetes in the general practice population,
this difference was not statistically significant. This con-
flicts with earlier research, in which diabetes was found to
be a risk factor for tendinopathy [29]. It is possible that
our relatively small study population explains this differ-
ence in outcomes. There is evidence that diabetes can
alter tendon structure, possibly through an excess of ad-
vanced glycation end products as a result of hypergly-
caemia [17]. In this study, we did not look into the levels
of blood glucose in the patients with diabetes. In general,
Dutch patients who are being checked by their general
practitioner or practice nurse are well regulated. However,
we cannot exclude the possibility that poorly regulated or
not yet diagnosed patients with diabetes were in the data-
set. Gaida et al. have questioned whether the higher risk
of tendinopathy associated with diabetes is caused by a
disturbance in glucose metabolism per se. They proposed
that the higher risk might have to be attributed to the
overweight associated with diabetes [30, 31]. The influence
of overweight on tendinopathy has been explained in two
different ways. One of the theories is that the extra weight
leads to an increased loading of the tendons. However, this
theory does not explain why non-weight bearing tendons
also more often develop tendinopathy in overweight per-
sons [11]. Another theory is that lipocytes have an effect
on tendon structure by their metabolic activity [30]. In a
recent review on tendinopathy in athletes, Scott et al. state
there is evidence for both a mechanical effect and a sys-
temic effect, but the relative contributions of the two
mechanisms should be further investigated [31]. In this
study, no exact data on BMI of the tendinopathy patients
were available.
There were no significant differences in the prevalence
of hypertension between the tendinopathy patients and
the practice population. Only few patients had dyslipi-
daemia, so we could not draw conclusions on the associ-
ation between dyslipidaemia and tendinopathy. We did
not have data on how well controlled the patients with
hypertension and dyslipidaemia were. Future research
could clarify whether developing tendinopathy is related
to levels of control of lipids and tension.
Although the use of corticosteroids and fluorquino-
lones has been identified as a risk factor for developing
tendinopathy [14, 15], in this study only few patients
were treated with corticosteroids or fluoroquinolones
before the start of the symptoms, so we could not draw
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conclusions on the association between the use of these
medications and tendinopathy. The percentage of tendino-
pathy patients using statins was not significantly different
from the percentage of people using antilipaemic drugs in
the total practice population. Marie et al. investigated re-
ports on statin-induced tendinous disorders and concluded
that these complications are very rare, given the large num-
ber of statin prescriptions [16]. The mechanism behind
these complications is unknown, but in a rat study De
Oliveira et al. described an association between statin treat-
ment and alterations in tendon metabolism [32].
Several factors could have influenced the outcomes of
this study. An important factor is the help-seeking be-
havior of patients and the organization of (para)medical
care in the Netherlands, which could have led to an
underestimation of the actual incidence and prevalence
of lower extremity tendinopathy in the general population.
People with musculoskeletal problems do not always seek
professional help. Picavet et al. state that half of the people
with musculoskeletal complaints visit a health care profes-
sional, and 33 to 42 % of people visit a general practitioner
for their complaints [33]. In addition, since 2006 patients
do not need to be referred by their general practitioner to
visit a physical therapist. Podotherapists are directly ac-
cessible since 2011, and in the studied time frame patients
did not need to be referred by their general practitioner to
visit a sports physician either. People with tendinopathy
symptoms could therefore have gone directly to one of
these healthcare professionals, instead of visiting their
general practitioner. Another factor which could have
influenced the outcomes, is the use of ICPC codes. Al-
though a wide combination of ICPC codes was used to
identify the cases, it is possible that some cases were
missed. A general practitioner could have accidentally
given the wrong ICPC code to a consult. In the current
study, one case of Achilles tendinopathy was found under
the ICPC code L15 (knee complaints).
A factor that could have led to an overestimation of
the actual incidence and prevalence of lower extremity
tendinopathy, is the inclusion of the greater trochanteric
pain syndrome. Although most cases of greater trochan-
teric pain syndrome are caused by gluteal tendinopathy
[34–36], there is a possibility that in some patients the
pain was caused by e.g. primary trochanteric bursitis or
referred pain from degenerative joint disease.
As this study focused on the epidemiology in primary
care, we followed the clinical description and diagnosis
as performed by the general practitioners. This entails
that the diagnoses were not confirmed by medical im-
aging as general practitioners rarely order diagnostic im-
aging when a tendinopathy is suspected. As this was not
the scope of this study, validation of these clinical diag-
noses by adding additional investigations like medical
imaging should be object of future research.
A strength of this study is that it provides insight into
the incidence and prevalence of lower extremity tendi-
nopathy among the general practice population, which
was currently lacking. It also provides an easily applic-
able search strategy that allows to investigate multiple
tendinopathies at the same time. Limitations of this
study are the retrospective design and the relatively
small study population, which might hinder extrapola-
tion of the results. However, the numbers for Achilles
tendinopathy in the current study were similar to those
found by De Jonge et al., who collected data from differ-
ent geographical locations in the Netherlands [2].
Conclusions
Lower extremity tendinopathy has an incidence rate of
10.52 per 1000 person-years and a prevalence rate of
11.83 per 1000 person-years in a Dutch general practice
population. In contrast to other research, in this general
population sample the prevalence of tendinopathy was
not higher in patients with diabetes or patients with
hypertension. The mean age of the tendinopathy patients
was higher than the mean age of the general practice
population. In only 29.4 % of the cases, a relationship
with sports was described. This indicates that tendinopathy
is not only a sports injury, but is common in non-athletes
as well. Lower extremity tendinopathy as common and
bothersome condition deserves a higher place on the
agenda of locomotor system research in order to develop
more effective preventive interventions.
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